Document Detail


Increase of neutral endopeptidase-24.11 with cellular density and enzyme modulation with an inhibitor on human Reh6 cell line.
MedLine Citation:
PMID:  1533518     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Neutral endopeptidase (EC 3.4.24.11, NEP) is an ectoenzyme, identified as the common acute lymphoblastic leukemia antigen (CALLA, CD10). This enzyme is involved in the inactivation of regulatory peptides such as enkephalins and atrial natriuretic peptide and its expression on the cell surface is therefore essential. NEP levels have been measured under different conditions on leukemic cell lines. NEP activity per cell was found to increase during the cell growth of Reh6 and CEM cells, a cell-cell contact mechanism being suggested by experiments using Transwell cell chambers. The same process was not observed with ICIG-7 fibroblasts. The numbers of enzymatic sites was also found to be selectively modulated by treatment with 0.1 microM N-[3-(R,S)-[(hydroxyamino)carbonyl]-2-benzyl-1-oxopropyl]glycine (HACBOGly), a potent (Ki = 1.4 nM) and specific inhibitor of NEP. A maximal 13% decrease in sites was observed after 8 hr incubation, this effect disappearing after 12 hr. This weak but specific negative modulation was not observed with a compound, chemically related to HACBOGly, which has a 10,000-fold lower inhibitory potency. The modulation was inhibited by low temperature or monensin treatment and could be brought about by an internalization of the enzyme, compensated for by an increased biosynthesis or by the sequestration of NEP in a non-membranous compartment.
Authors:
P E Milhiet; A Beaumont; C Garbay-Jaureguiberry; B P Roques
Related Documents :
3770298 - Effect of phorbol esters and liposome-delivered phospholipids on the differentiation pr...
6383928 - Inhibition of phorbol-ester-induced adhesion of differentiating human myeloid leukemic ...
6327718 - Changes in cell shape correlate with collagenase gene expression in rabbit synovial fib...
9495248 - Pma-induced reduction in invasiveness is associated with hyperphosphorylation of marcks...
9733148 - The effects of aging on the expression of glutathione s-transferases in the testis and ...
1370958 - Tenascin expression in human glioma cell lines and normal tissues.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Biochemical pharmacology     Volume:  43     ISSN:  0006-2952     ISO Abbreviation:  Biochem. Pharmacol.     Publication Date:  1992 Apr 
Date Detail:
Created Date:  1992-06-01     Completed Date:  1992-06-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0101032     Medline TA:  Biochem Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1711-5     Citation Subset:  IM    
Affiliation:
Département de Chimie Organique, U266 INSERM-UA498 CNRS, Faculté de Pharmacie, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antigens, Differentiation / metabolism*
Antigens, Neoplasm / metabolism*
Cell Line / drug effects,  enzymology
Cell Membrane / drug effects,  metabolism
Glycine / analogs & derivatives,  antagonists & inhibitors,  pharmacology
Humans
Hydroxylamines / antagonists & inhibitors,  pharmacology
Monensin / pharmacology
Neprilysin / antagonists & inhibitors,  metabolism*
Temperature
Chemical
Reg. No./Substance:
0/Antigens, Differentiation; 0/Antigens, Neoplasm; 0/Hydroxylamines; 17090-79-8/Monensin; 56-40-6/Glycine; 99026-94-5/N-(3-hydroxyaminocarbonyl-2-benzyl-1-oxopropyl)glycine; EC 3.4.24.11/Neprilysin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Biochemical and thermodynamic aspects of the binding of [3H]glycine to its strychnine-insensitive re...
Next Document:  Distinct mechanisms of inhibition of purified cardiac sarcolemma Ca(2+)-ATPase by two calmodulin ant...